Intercept Pharma is One Step Closer to Filing for Approval of First NASH Treatment

Intercept Pharma is One Step Closer to Filing for Approval of First NASH Treatment

The 2019 pipeline report: Changing the treatment paradigm

The 2019 pipeline report: Changing the treatment paradigm

Is the Smoldering NASH Market Ready to Burst Into Flames?

Is the Smoldering NASH Market Ready to Burst Into Flames?

NASH drugs come into focus as field awaits late-stage data

NASH drugs come into focus as field awaits late-stage data

Pfizer and Novartis Ink Deal to Test Combination Therapies for NASH

Pfizer and Novartis Ink Deal to Test Combination Therapies for NASH